Journey Medical NASDAQ DERM Reports 21 Revenue Growth in Q1 2026 Remains Unprofitable Xi Warns Trump Mishandling Taiwan Could Put USChina Relationship in Great Jeopardy Inspire INSP Q1 2026 Results Fall Short EPS 039 Revenue NA